Literature DB >> 33790635

Characteristics and Behaviors Associated with Prevalent SARS-CoV-2 Infection.

Sidney Aung1, Eric Vittinghoff2, Gregory Nah1, Noah D Peyser1, Mark J Pletcher2, Jeffrey E Olgin1, Gregory M Marcus1.   

Abstract

INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (Covid-19), has been a serious threat to global health. Previous work has focused primarily on hospitalized patients or on identifying risk factors for disease severity and mortality once the infection has taken place. We sought to leverage the ubiquity of smartphones and mobile applications to study risk factors for Covid-19 infection in a large, geographically heterogenous cohort.
METHODS: We analyzed data obtained from the Covid-19 Citizen Science (CCS) Study, a worldwide, mobile application-based cohort. After employing forward selection to identify variables with p values < 0.1, multivariable logistic regression models were utilized to identify independent risk factors associated with prevalent SARS-CoV-2 infection.
RESULTS: Among 36,041 participants in 113 countries and all 50 states in the US, 484 participants had prevalent SARS-CoV-2 infection. After multivariable adjustment, being a healthcare worker, living with at least one school-aged child, having pets at home, and having immunodeficiency were each associated with an increased odds of SARS-CoV-2. The association between pets and prevalent SARS-CoV-2 was driven by dog ownership. After adjustment for the same covariates, Asian or Pacific Islander race, receiving a flu shot within the past year, increased level of education, and smoking or vaping marijuana within the last 30 days were each associated with a lower odds of SARS-CoV-2.
CONCLUSION: We identified various characteristics and behaviors, many of which are potentially modifiable, associated with prevalent SARS-CoV-2 infection in a world-wide mobile application-based cohort.
© 2021 Aung et al.

Entities:  

Keywords:  COVID-19; cohort study; digital health; epidemiology; mobile applications

Year:  2021        PMID: 33790635      PMCID: PMC8006955          DOI: 10.2147/IJGM.S305990

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


Introduction

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (Covid-19), has had a significant impact on communities across the globe. Identifying risk factors associated with Covid-19 may prove valuable to the delivery of targeted public health interventions, providing more personalized advice to high-risk patient populations, and better informing the global response to the pandemic. Participation among community members and organizations has played a key role during the Covid-19 pandemic,1 and identifying potentially modifiable risk factors that can support community-based interventions is vital for containment of the pandemic. Previous work has focused on hospitalized patients2 or on disease severity and mortality once infection has taken place.3 Furthermore, smartphone technology on its own, and as an extension of telemedicine, has had various applications during the Covid-19 pandemic.4 We therefore sought to leverage the ubiquity of smartphones and mobile applications to study risk factors for Covid-19 infection in a large, geographically heterogenous cohort.

Methods

We conducted a cross-sectional study using data obtained from the Covid-19 Citizen Science (CCS) Study, a worldwide, mobile application-based cohort (. Surveys pertinent to the current analyses are included in the . Questions where “effect-cause” relationships could obscure inferred causal relationships with prevalent disease were excluded. Prevalent SARS-CoV-2 infection was defined as a history of a positive polymerase chain reaction (PCR) test for active infection. Participants were initially screened in the baseline survey for a history of any positive test for infection. Given an affirmative response to that initial question, participants were asked to distinguish between a PCR test for active infection versus an antibody test for prior infection. Self-report was verified by documentation of test results (). We identified variables exhibiting p values < 0.1 for associations with prevalent disease after adjusting for age, sex, race/ethnicity and then employed forward selection in a multivariable logistic regression model, retaining variables with p values < 0.1. Statistical analyses were performed using Stata, version 16 (College Station, TX). Two-tailed p-values < 0.05 were considered statistically significant. The study was approved by the University of California, San Francisco Institutional Review Board. All participants provided informed electronic consent.

Results

Among 36,041 participants in 113 countries and all 50 states in the US, 484 participants had prevalent SARS-CoV-2 infection () (4297 participants had a negative test, and 31,260 participants were not tested). Baseline participant characteristics are shown in Table 1. After multivariable adjustment, being a healthcare worker, living with at least one school-aged child, having pets at home, and having immunodeficiency were each associated with an increased odds of SARS-CoV-2 (Figure 1). The association between pets and prevalent SARS-CoV-2 was driven by dog ownership ( and ). After multivariable adjustment for the same covariates, Asian or Pacific Islander race, receiving a flu shot within the past year, increased level of education, and smoking or vaping marijuana within the last 30 days were each associated with a lower odds of SARS-CoV-2 (Figure 1).
Table 1

Baseline Characteristics of Participants with and without a Positive SARS-CoV-2 Test for Active Infection

Tested PositiveN=484Everyone Else (Tested Negative, Not Tested)N=35,557p-value
Primary Residence in USA461 (95.2%)32,989 (92.8%)0.033
Median Age (IQR)42.0 (36.0–51.0)a43.0 (35.0–54.0)b0.17
Female Biological Sex361 (75.8%)23,163 (65.1%)<0.001
Race/Ethnicity<0.001
White403 (84.7%)28,902 (81.3%)
Black7 (1.5%)336 (0.9%)
Hispanic (any race)47 (9.9%)2581 (7.3%)
Asian or Pacific Islander10 (2.1%)1919 (5.4%)
Other (including multiracial)9 (1.9%)813 (2.3%)
Highest Level of Education<0.001
Less than high school3 (0.6%)164 (0.5%)
High school graduate27 (5.7%)1356 (3.8%)
College Graduate (including associate degree)268 (55.4%)17,552 (49.4%)
Graduate school171 (35.3%)15,035 (42.3%)
Other7 (1.4%)427 (1.2%)
Healthcare worker181 (37.4%)7299 (20.5%)<0.001
Children living with you205 (42.4%)11,529 (32.4%)<0.001
Children home from college living with you40 (8.3%)2778 (7.8%)0.67
Any pets at home357 (73.8%)22, 882 (64.4%)<0.001
Cigarettes: any use in last 30 days25 (5.4%)1906 (5.4%)0.92
E-cigarettes: any use in last 30 days13 (2.8%)1041 (2.9%)0.89
Marijuana: any use in last 30 days31 (6.8%)3300 (9.3%)0.027
Atrial fibrillation7 (1.5%)952 (2.7%)0.09
Anemia54 (11.4%)3512 (9.9%)0.36
Asthma52 (11.0%)3482 (9.8%)0.49
Cancer14 (3.0%)1023 (2.9%)1.00
Coronary artery disease8 (1.7%)825 (2.2%)0.45
Congestive heart failure3 (0.6%)220 (0.6%)1.00
Chronic obstructive pulmonary disease10 (2.1%)569 (1.6%)0.46
Diabetes18 (3.8%)1400 (3.9%)0.91
High blood pressure86 (18.1%)6777 (19.1%)0.48
Human immunodeficiency virus4 (0.8%)139 (0.4%)0.13
Immunodeficiency20 (4.2%)701 (2.0.%)0.003
Myocardial infarct3 (0.6%)340 (1.0%)0.64
Pregnant10 (2.1%)306 (0.9%)0.011
Sleep apnea45 (9.5%)3578 (10.1%)0.60
Stroke5 (1.1%)433 (1.2%)1.00
Received flu shot within the year352 (72.9%)26,258 (73.8%)0.64

Notes: aThe youngest and oldest ages of participants within the “Tested Positive” group was 18 years and 78 years, respectively. bThe youngest and oldest ages of participants within the “Everyone Else” group was 18 years and 91 years, respectively.

Figure 1

Forest plot of adjusted odds ratios for participants with prevalent positive SARS-CoV-2 test results. Race/ethnicity categories were compared against non-Hispanic white participants. Y error bars indicate 95% confidence intervals.

Baseline Characteristics of Participants with and without a Positive SARS-CoV-2 Test for Active Infection Notes: aThe youngest and oldest ages of participants within the “Tested Positive” group was 18 years and 78 years, respectively. bThe youngest and oldest ages of participants within the “Everyone Else” group was 18 years and 91 years, respectively. Forest plot of adjusted odds ratios for participants with prevalent positive SARS-CoV-2 test results. Race/ethnicity categories were compared against non-Hispanic white participants. Y error bars indicate 95% confidence intervals.

Discussion

We identified characteristics associated with prevalent SARS-CoV-2 infection in a world-wide mobile application-based cohort. Our observation that healthcare workers experience a higher likelihood of infection has biological plausibility and fits with previous evidence.5 Although disease transmission has been described from children6 and may theoretically occur from pets,7 these data suggest that each may be an independent risk factor for infection. A higher risk among dog owners may arise from environmental exposures during dog-walking or fomite-based exposure from dog petting. Although previous evidence demonstrates a higher risk of infection among black and LatinX individuals,8 here we found that Asians experience the lowest risk. A higher degree of education is commonly a protective factor against disease. The observation that recent marijuana smoking or vaping was associated with a lower risk was surprising—while it is possible this reflected “effect-cause” (for example, those feeling ill were less likely to use the drug), we did not find a similar association with e-cigarettes or smoking tobacco. While the flu vaccine would not be considered to confer cross-immunity with coronaviruses, the lower risk among those who received the flu shot could reflect more overall healthy behaviors or perhaps reflects a general immune system boost that renders individuals less prone to viral infection. While a strength of the current study is that it was not constrained to individuals seeking medical care, we acknowledge that we cannot exclude residual or unmeasured confounding in this observational study and that our study population, all with smartphones, does not necessarily reflect the general population. We also relied on interpretation from participants regarding what constituted a personal history of immunodeficiency, where immunodeficiency represents a broad phenomenon, though we included separate survey questions assessing a history of more specific immunosuppressive conditions such as for diabetes and human immunodeficiency virus (HIV). There is also the possibility that those who smoke or vape marijuana may have been less likely to receive SARS-CoV-2 testing, which could have ultimately contributed to the observed inverse relationship between smoking or vaping marijuana and prevalent SARS-CoV-2 infections. Furthermore, the analyses treated participants who were not tested for SARS-CoV-2 infection as if they had not been infected and we acknowledge that there may have been participants in this group with prevalent infections that were therefore under-ascertained. We do not believe this would have led to spurious false-positive results, but on the contrary, this may have led to underestimating the strengths of our observed relationships.

Conclusion

In conclusion, we identified various characteristics and behaviors, many of which are potentially modifiable, that are associated with prevalent SARS-CoV-2 infection in a world-wide mobile application-based cohort. We believe that these findings will be broadly useful for targeted public health interventions in efforts to further contain the pandemic.
  8 in total

1.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.

Authors:  Safiya Richardson; Jamie S Hirsch; Mangala Narasimhan; James M Crawford; Thomas McGinn; Karina W Davidson; Douglas P Barnaby; Lance B Becker; John D Chelico; Stuart L Cohen; Jennifer Cookingham; Kevin Coppa; Michael A Diefenbach; Andrew J Dominello; Joan Duer-Hefele; Louise Falzon; Jordan Gitlin; Negin Hajizadeh; Tiffany G Harvin; David A Hirschwerk; Eun Ji Kim; Zachary M Kozel; Lyndonna M Marrast; Jazmin N Mogavero; Gabrielle A Osorio; Michael Qiu; Theodoros P Zanos
Journal:  JAMA       Date:  2020-05-26       Impact factor: 56.272

Review 2.  COVID-19 and applications of smartphone technology in the current pandemic.

Authors:  Karthikeyan Iyengar; Gaurav K Upadhyaya; Raju Vaishya; Vijay Jain
Journal:  Diabetes Metab Syndr       Date:  2020-05-26

3.  Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.

Authors:  Matthew J Cummings; Matthew R Baldwin; Darryl Abrams; Samuel D Jacobson; Benjamin J Meyer; Elizabeth M Balough; Justin G Aaron; Jan Claassen; LeRoy E Rabbani; Jonathan Hastie; Beth R Hochman; John Salazar-Schicchi; Natalie H Yip; Daniel Brodie; Max R O'Donnell
Journal:  Lancet       Date:  2020-05-19       Impact factor: 79.321

4.  Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population.

Authors:  Farhaan S Vahidy; Juan Carlos Nicolas; Jennifer R Meeks; Osman Khan; Alan Pan; Stephen L Jones; Faisal Masud; H Dirk Sostman; Robert Phillips; Julia D Andrieni; Bita A Kash; Khurram Nasir
Journal:  BMJ Open       Date:  2020-08-11       Impact factor: 2.692

Review 5.  COVID-19 pandemic: current knowledge about the role of pets and other animals in disease transmission.

Authors:  Mulugeta Kiros; Henok Andualem; Teklehaimanot Kiros; Wasihun Hailemichael; Sisay Getu; Alene Geteneh; Derbie Alemu; Woldaregay Erku Abegaz
Journal:  Virol J       Date:  2020-10-02       Impact factor: 4.099

6.  Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020.

Authors:  Young Joon Park; Young June Choe; Ok Park; Shin Young Park; Young-Man Kim; Jieun Kim; Sanghui Kweon; Yeonhee Woo; Jin Gwack; Seong Sun Kim; Jin Lee; Junghee Hyun; Boyeong Ryu; Yoon Suk Jang; Hwami Kim; Seung Hwan Shin; Seonju Yi; Sangeun Lee; Hee Kyoung Kim; Hyeyoung Lee; Yeowon Jin; Eunmi Park; Seung Woo Choi; Miyoung Kim; Jeongsuk Song; Si Won Choi; Dongwook Kim; Byoung-Hak Jeon; Hyosoon Yoo; Eun Kyeong Jeong
Journal:  Emerg Infect Dis       Date:  2020-07-16       Impact factor: 6.883

7.  Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study.

Authors:  Long H Nguyen; David A Drew; Mark S Graham; Amit D Joshi; Chuan-Guo Guo; Wenjie Ma; Raaj S Mehta; Erica T Warner; Daniel R Sikavi; Chun-Han Lo; Sohee Kwon; Mingyang Song; Lorelei A Mucci; Meir J Stampfer; Walter C Willett; A Heather Eliassen; Jaime E Hart; Jorge E Chavarro; Janet W Rich-Edwards; Richard Davies; Joan Capdevila; Karla A Lee; Mary Ni Lochlainn; Thomas Varsavsky; Carole H Sudre; M Jorge Cardoso; Jonathan Wolf; Tim D Spector; Sebastien Ourselin; Claire J Steves; Andrew T Chan
Journal:  Lancet Public Health       Date:  2020-07-31
  8 in total
  2 in total

1.  Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination.

Authors:  Alexis L Beatty; Noah D Peyser; Xochitl E Butcher; Jennifer M Cocohoba; Feng Lin; Jeffrey E Olgin; Mark J Pletcher; Gregory M Marcus
Journal:  JAMA Netw Open       Date:  2021-12-01

2.  Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK).

Authors:  Mohammad Talaei; Sian Faustini; Hayley Holt; David A Jolliffe; Giulia Vivaldi; Matthew Greenig; Natalia Perdek; Sheena Maltby; Carola M Bigogno; Jane Symons; Gwyneth A Davies; Ronan A Lyons; Christopher J Griffiths; Frank Kee; Aziz Sheikh; Alex G Richter; Seif O Shaheen; Adrian R Martineau
Journal:  BMC Med       Date:  2022-02-22       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.